Accelerate Diagnostics

United States
Hope Valley, Rhode Island, United States, 85714

Company profile

Accelerate Diagnostics company profile

Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity. It was founded in 2004 and is headquartered in Tucson, Arizona.

Business identity

Contact email
[email protected]
Phone number
520-365-3100
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2004-01-01, Year

Headquarters

Postal code
85714
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
12
Total equity funding
$263.5M
Last funding
Post IPO Equity / $15M / 2024-01-19
Last equity funding
Post IPO Equity / $15M
Investors
4
Lead investors
1
Articles
103
Exited on
2012-12-26

Founders and investors

Lead investors

CARB-X

Investors

CARB-XJack W. Schuler Living TrustOracleSchuler Family Foundation